Is Biopsy-Free Embryo Screening on the Horizon?

Fertility AuthorityDr. Evan Rosenbluth, a reproductive endocrinologist with Reproductive Science Center of the Bay Area has performed award-winning research studying non-invasive methods for determining embryo implantation potential. Biopsies – including preimplantation genetic screening or PGS – are invasive and can add can $5,000 to $6,000 to an IVF cycle, he says. Currently that is the best option for determining which embryos are chromosomally normal. His goal is to develop biopsy-free methods for selecting healthy embryos.

Read More